These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 8139995)

  • 61. Community health outreach program of the Chad-Cameroon petroleum development and pipeline project.
    Utzinger J; Wyss K; Moto DD; Tanner M; Singer BH
    Clin Occup Environ Med; 2004 Feb; 4(1):9-26. PubMed ID: 15043361
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Management of cytostatic drugs by nurses: analysis of preliminary results].
    Bilski B
    Med Pr; 2004; 55(3):243-7. PubMed ID: 15493499
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Avoiding accidental exposure to intravenous cytotoxic drugs.
    Meade E
    Br J Nurs; 2014 Sep 11-24; 23(16):S34, S36-9. PubMed ID: 25203853
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Recommendations for handling cytotoxic drugs in hospitals.
    Stolar MH; Power LA; Viele CS
    Am J Hosp Pharm; 1983 Jul; 40(7):1163-71. PubMed ID: 6881154
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Safe handling of cytotoxic agents: a team approach.
    Willemsen-McBride T; Gehan K
    AORN J; 2009 Nov; 90(5):731-2, 735-40. PubMed ID: 19895929
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Principles of chemotherapy safety procedures.
    Takada S
    Clin Tech Small Anim Pract; 2003 May; 18(2):73-4. PubMed ID: 12831064
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Medical surveillance for neurologic endpoints.
    Cone JE; Bowler R; So Y
    Occup Med; 1990; 5(3):547-62. PubMed ID: 2218802
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Worker exposure to 1,3,5-triglycidyl isocyanurate (TGIC) in powder paint coating operations.
    Allmaras S
    Appl Occup Environ Hyg; 2003 Mar; 18(3):151-3. PubMed ID: 12573957
    [No Abstract]   [Full Text] [Related]  

  • 69. Association between occupational exposure levels of antineoplastic drugs and work environment in five hospitals in Japan.
    Yoshida J; Koda S; Nishida S; Yoshida T; Miyajima K; Kumagai S
    J Oncol Pharm Pract; 2011 Mar; 17(1):29-38. PubMed ID: 20699333
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Preventing the contamination of hospital personnel by cytotoxic agents: evaluation and training of the para-professional healthcare workers in oncology units.
    Kieffer C; Verhaeghe P; Lagrassa S; Grégoire R; Moussaoui Z; Casteras-Ducros C; Clark JE; Vanelle P; Rathelot P
    Eur J Cancer Care (Engl); 2015 May; 24(3):404-10. PubMed ID: 25289934
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Chemotherapy drugs put health care workers at risk.
    Nelson R
    Am J Nurs; 2010 Nov; 110(11):19-21. PubMed ID: 20980888
    [No Abstract]   [Full Text] [Related]  

  • 72. As debate over asbestos risks rages worker health remains central issue.
    O'Mara L
    Occup Health Saf; 1992 Mar; 61(3):29-30. PubMed ID: 1589185
    [No Abstract]   [Full Text] [Related]  

  • 73. Testing an Intervention to Decrease Healthcare Workers' Exposure to Antineoplastic Agents.
    Graeve C; McGovern PM; Arnold S; Polovich M
    Oncol Nurs Forum; 2017 Jan; 44(1):E10-E19. PubMed ID: 27991608
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Medical surveillance and biomonitoring for occupational cancer endpoints.
    Cone JE; Rosenberg J
    Occup Med; 1990; 5(3):563-81. PubMed ID: 2218803
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Monitoring occupational exposure to cancer chemotherapy drugs.
    Baker ES; Connor TH
    Am J Health Syst Pharm; 1996 Nov; 53(22):2713-23. PubMed ID: 8931813
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Occupational exposure to antineoplastic drugs in seven Italian hospitals: the effect of quality assurance and adherence to guidelines.
    Turci R; Minoia C; Sottani C; Coghi R; Severi P; Castriotta C; Del Bianco M; Imbriani M
    J Oncol Pharm Pract; 2011 Dec; 17(4):320-32. PubMed ID: 20823049
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Use of personal protective equipment under occupational exposure to cytostatics].
    Krzemińska S; Pośniak M; Szewczyńska M
    Med Pr; 2016; 67(4):499-508. PubMed ID: 27623830
    [TBL] [Abstract][Full Text] [Related]  

  • 78. How do nurses manage their occupational exposure to cytotoxic drugs? A descriptive survey in chemotherapy settings, Shiraz, Iran.
    Momeni M; Danaei M; Askarian M
    Int J Occup Environ Med; 2013 Apr; 4(2):102-6. PubMed ID: 23567536
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Chemotherapy exposure file.
    Young RL; Du Vall EM
    Am J Hosp Pharm; 1985 Sep; 42(9):1990-1. PubMed ID: 3840330
    [No Abstract]   [Full Text] [Related]  

  • 80. Drugs hazardous to healthcare workers. Evaluation of methods for monitoring occupational exposure to cytostatic drugs.
    Sessink PJ; Bos RP
    Drug Saf; 1999 Apr; 20(4):347-59. PubMed ID: 10230582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.